Media release from Professor Ian Brighthope, Director of Nutrition and Environmental Medicine, NIIM

Date: 06-07-2021

Media Release

NIIM conducts Circulating Tumour Cells (CTC) tests as part of an observational study that has been registered with the Australian and New Zealand Clinical Trials Registry (ANZCTR).

The ISET CTC test is a screening test, not a diagnostic test, that aims to provide a biomarker for the early detection of cancer and can be used by a patient’s treating doctor as part of their individual treatment plan.

NIIM was founded by medical practitioners to provide patients with pioneering and scientifically validated treatments. We are proud to contribute to the scientific evidence base showing integrative medicine can help address complex illnesses and improve health outcomes for Australians.”

Professor Ian Brighthope
Director, Nutritional & Environmental Medicine